I

Inter Pharma PCL
SET:IP

Watchlist Manager
Inter Pharma PCL
SET:IP
Watchlist
Price: 5.05 THB
Market Cap: ฿3.1B

Wall St Price Targets

IP Price Targets Summary
Inter Pharma PCL

There are no price targets for IP.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Inter Pharma PCL Competitors:
Price Targets

Revenue
Forecast

37% / Year
Past Growth
27% / Year
Estimated Growth
Estimates Accuracy
-24%
Average Miss
37% / Year
Past Growth
27% / Year
Estimated Growth
Estimates Accuracy
-24%
Average Miss

Over the last 9 years, the compound annual growth rate for Revenue has been 37%. The projected CAGR for the next 1 year is 27%.

Gross Profit
Forecast

30% / Year
Past Growth
-10% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
30% / Year
Past Growth
-10% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 9 years, the compound annual growth rate for Gross Profit has been 30%. The projected CAGR for the next 3 years is -10%.

Operating Income
Forecast

24% / Year
Past Growth
51% / Year
Estimated Growth
Estimates Accuracy
-25%
Average Miss
24% / Year
Past Growth
51% / Year
Estimated Growth
Estimates Accuracy
-25%
Average Miss

Over the last 9 years, the compound annual growth rate for Operating Income has been 24%. The projected CAGR for the next 1 year is 51%.

Pre-Tax Income
Forecast

23% / Year
Past Growth
0% / Year
Estimated Growth
Estimates Accuracy
-15%
Average Miss
23% / Year
Past Growth
0% / Year
Estimated Growth
Estimates Accuracy
-15%
Average Miss

Over the last 9 years, the compound annual growth rate for Pre-Tax Income has been 23%. The projected CAGR for the next 3 years is 0%.

Net Income
Forecast

26% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-31%
Average Miss
26% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-31%
Average Miss

Over the last 9 years, the compound annual growth rate for Net Income has been 26%. The projected CAGR for the next 2 years is 19%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is IP's stock price target?
Not Available

IP does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Inter Pharma PCL?
Projected CAGR
27%

Over the last 9 years, the compound annual growth rate for Revenue has been 37%. The projected CAGR for the next 1 year is 27%.

What is the Gross Profit forecast for Inter Pharma PCL?
Projected CAGR
-10%

Over the last 9 years, the compound annual growth rate for Gross Profit has been 30%. The projected CAGR for the next 3 years is -10%.

What is the Operating Income forecast for Inter Pharma PCL?
Projected CAGR
51%

Over the last 9 years, the compound annual growth rate for Operating Income has been 24%. The projected CAGR for the next 1 year is 51%.

What is the Pre-Tax Income forecast for Inter Pharma PCL?
Projected CAGR
0%

Over the last 9 years, the compound annual growth rate for Pre-Tax Income has been 23%. The projected CAGR for the next 3 years is 0%.

What is the Net Income forecast for Inter Pharma PCL?
Projected CAGR
19%

Over the last 9 years, the compound annual growth rate for Net Income has been 26%. The projected CAGR for the next 2 years is 19%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett